Trial Profile
A Study to Evaluate the Use of Ferumoxytol as a MRI Contrast Agent in Patients With Osteomyelitis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2016
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Osteomyelitis
- Focus Diagnostic use
- 21 Jan 2016 New trial record
- 08 Dec 2015 Interim results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology (n = 8).